Person

Michael G. Erickson

Executive Vice President, Idexx Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$3.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 17, 2026IDXXSale456$623.76$284K
Feb 17, 2026IDXXSale204$625.24$128K
Feb 17, 2026IDXXSale1,288$626.26$807K
Feb 17, 2026IDXXSale2,694$628.22$1.7M
Feb 17, 2026IDXXSale689$629.09$433K
Feb 17, 2026IDXXSale40$629.86$25K
Aug 12, 2025IDXXSale88$649.85$57K
Aug 12, 2025IDXXSale318$649.99$207K

SEC reporting-owner ID (CIK) 2005385 · all filings on EDGAR